Education
About Us
Working with TipRanks
Follow Us
AdaptHealth (AHCO)
NASDAQ:AHCO
AHCO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.11 - $11.90
Previous CloseN/A
Volume245.49K
Average Volume (3M)1.41M
Market Cap
$1.20B
Enterprise Value$3.18B
Total Cash (Recent Filing)$109.75M
Total Debt (Recent Filing)$2.13B
Price to Earnings (P/E)15.6
Beta0.95
Next Earnings
Aug 12, 2025EPS Estimate
0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.03
Shares Outstanding134,947,900
10 Day Avg. Volume845,049
30 Day Avg. Volume1,413,233
Financial Highlights & Ratios
PEG Ratio0.09
Price to Book (P/B)0.73
Price to Sales (P/S)0.00
P/FCF Ratio4.91
Enterprise Value/Market Cap2.66
Enterprise Value/Revenue0.24
Enterprise Value/Gross Profit4.83
Enterprise Value/Ebitda5.93
Forecast
1Y Price Target
$13.33Price Target Upside47.78% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
AdaptHealth News
PremiumCompany Announcements
AdaptHealth Reports Q1 2025 Financial Results
PremiumCompany Announcements
AdaptHealth’s Mixed Earnings Call Highlights Progress and Challenges
Bulls Say, Bears Say
Bulls Say
Free Cash FlowAHCO reported a strong free cash flow of $73 million in Q4, representing a 10% year-over-year growth.
Strategic DivestituresAHCO continues to deliver on initiatives to strategically divest ~$100m of annual revenues with non-core asset sales.
Bears Say
Earnings PerformanceEPS of -$0.05 came in below the analyst estimate.
EBITDA Margin DeclineEBITDA margin declined to 16.4%, showing a decrease of 360 basis points year over year.
Revenue OutlookAHCO lowered its 2025 revenue outlook and EBITDA forecast, partially due to the new asset sale announcement.
Ownership Overview
3.49% Insiders
21.95% Mutual Funds
6.06% Other Institutional Investors
46.70% Public Companies and Individual Investors
AHCO FAQ
What was AdaptHealth’s price range in the past 12 months?
AdaptHealth lowest stock price was $7.11 and its highest was $11.90 in the past 12 months.
What is AdaptHealth’s market cap?
AdaptHealth’s market cap is $1.20B.
When is AdaptHealth’s upcoming earnings report date?
AdaptHealth’s upcoming earnings report date is Aug 12, 2025 which is in 67 days.
How were AdaptHealth’s earnings last quarter?
AdaptHealth released its earnings results on May 06, 2025. The company reported $0.027 earnings per share for the quarter, missing the consensus estimate of $0.047 by -$0.02.
Is AdaptHealth overvalued?
According to Wall Street analysts AdaptHealth’s price is currently Undervalued.
Does AdaptHealth pay dividends?
AdaptHealth does not currently pay dividends.
What is AdaptHealth’s EPS estimate?
AdaptHealth’s EPS estimate is 0.15.
How many shares outstanding does AdaptHealth have?
AdaptHealth has 134,947,900 shares outstanding.
What happened to AdaptHealth’s price movement after its last earnings report?
AdaptHealth reported an EPS of $0.027 in its last earnings report, missing expectations of $0.047. Following the earnings report the stock price went up 1.724%.
Which hedge fund is a major shareholder of AdaptHealth?
Currently, no hedge funds are holding shares in AHCO
AdaptHealth Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$13.33 (47.78% Upside)
$13.33 (47.78% Upside)
Blogger Sentiment
Bullish
AHCO Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 1.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $327.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.4%
Last 30 Days ▼ 6.8%
Last 30 Days ▼ 6.8%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-4.52%
12-Months-Change
Fundamentals
Return on Equity
5.12%
Trailing 12-Months
Asset Growth
-1.47%
Trailing 12-Months
Company Description
AdaptHealth
AdaptHealth Corp. (AHCO) is a leading provider of home healthcare equipment, supplies, and services in the United States. The company operates in the healthcare sector, focusing on enhancing the quality of life for patients with chronic diseases and aging populations. AdaptHealth offers a comprehensive range of products, including respiratory therapy, mobility aids, diabetes management supplies, and other durable medical equipment. With a robust distribution network, the company ensures timely delivery and support for patients and healthcare providers, facilitating improved patient care and outcomes.
AHCO Company Deck
AHCO Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call reflected a mixed performance, with notable achievements in debt reduction and improvements in the Respiratory and Diabetes Health segments. However, overall revenue and adjusted EBITDA declines, as well as challenges in the Sleep Health segment, balanced the positive aspects. The sentiment is neutral, reflecting both progress and ongoing challenges.Read More>AHCO Stock 12 Month Forecast
Average Price Target
$13.33
▲(47.78%Upside)
Technical Analysis
Ufp Technologies
―
LivaNova
―
Senseonics Holdings
―
Establishment Labs Holdings
―
Bioventus
―